CGEM News
Cullinan Therapeutics, Inc.
$15.56
+$0.72(+4.85%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
592.71K
52W Range
$6.73 - $23.19
Target Price
--
CGEM news: the latest Cullinan Therapeutics, Inc. headlines, press releases and market updates, newest first.
Latest CGEM News
- Cullinan’s New AML Trial: What CLN-049’s Phase 1b Combo Study Could Mean for CGEM InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 28, 2026
- Cullinan’s CLN-049 Trial Advances In High-Risk Blood Cancers, Keeping Investor Focus On CGEMTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 28, 2026
- Cullinan’s CLN-978 RA Trial: Early-Stage Catalyst in a Crowded Autoimmune MarketTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 20, 2026
- Cullinan’s CLN-978 RA Trial: Early-Stage Catalyst in a Crowded Autoimmune MarketTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 20, 2026
- Cullinan Management (CGEM) Gets a Buy from WedbushTipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
- Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Cullinan Management (CGEM)TipRanks Newsroom · Oct 7, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEM | $15.56 | +4.9% | 592.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cullinan Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW